- Home
- BSM vs VCEL Comparison
BSM vs VCEL Comparison
Compare BSM & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSM
- VCEL
- Stock Information
- Founded
- BSM 1876
- VCEL 1989
- Country
- BSM United States
- VCEL United States
- Employees
- BSM N/A
- VCEL N/A
- Industry
- BSM Oil & Gas Production
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BSM Energy
- VCEL Health Care
- Exchange
- BSM Nasdaq
- VCEL Nasdaq
- Market Cap
- BSM 2.6B
- VCEL 2.1B
- IPO Year
- BSM 2015
- VCEL 1997
- Fundamental
- Price
- BSM $12.46
- VCEL $35.86
- Analyst Decision
- BSM Hold
- VCEL Strong Buy
- Analyst Count
- BSM 1
- VCEL 7
- Target Price
- BSM $13.00
- VCEL $61.29
- AVG Volume (30 Days)
- BSM 540.2K
- VCEL 614.9K
- Earning Date
- BSM 08-04-2025
- VCEL 07-31-2025
- Dividend Yield
- BSM 9.49%
- VCEL N/A
- EPS Growth
- BSM N/A
- VCEL 2045.40
- EPS
- BSM 1.16
- VCEL 0.13
- Revenue
- BSM $413,675,000.00
- VCEL $249,119,000.00
- Revenue This Year
- BSM $11.07
- VCEL $23.03
- Revenue Next Year
- BSM $13.82
- VCEL $24.51
- P/E Ratio
- BSM $10.87
- VCEL $284.01
- Revenue Growth
- BSM N/A
- VCEL 16.13
- 52 Week Low
- BSM $11.96
- VCEL $33.09
- 52 Week High
- BSM $15.66
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- BSM 46.43
- VCEL 46.58
- Support Level
- BSM $11.96
- VCEL $35.24
- Resistance Level
- BSM $12.66
- VCEL $38.08
- Average True Range (ATR)
- BSM 0.24
- VCEL 1.80
- MACD
- BSM 0.03
- VCEL 0.09
- Stochastic Oscillator
- BSM 50.51
- VCEL 45.80
About BSM Black Stone Minerals L.P. Common units representing limited partner interests
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.